- Afatinib - non-small cell lung cancer in the second generation targeted therapy2014 | Publication without faculty affiliation
- Development of ventricular trabeculae affects electrical conduction in the early endothermic heart2024 | First Faculty of Medicine
- Quantitative RT-PCR as a tool solving discerepant results between ERBB2 gene copy numbers and expression of the ERBB -2 protein: An improvement of Herceptin therapy indication in breast carcinomasPublication without faculty affiliation
- Patients with neuregulin 1 (NRG1) rearranged cancer are suitable for the theranostic approach and targeted therapy2022 | Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Afatinib - clinical practice experience2018 | Second Faculty of Medicine
- Targeted treatment of NSCLC with kinase inhibitors - afatinib and nintedanib in clinical pracitce2017 | Faculty of Medicine in Pilsen
- Afatinib as first-line therapy of advanced lung cancer2014 | First Faculty of Medicine
- Prognostic significance of c-erbB-2 gene expression in pancreatic2001 | First Faculty of Medicine
- Prognostic signuficance of c-erbB-2 gene expression in pancreatic2001 | Faculty of Physical Education and Sport
- Starší pacientka léčená afatinibem2016 | First Faculty of Medicine
- Identification of tumors with NRG1 rearrangement, including a novel putative pathogenic UNC5D-NRG1 gene fusion in prostate cancer by data-drilling a de-identified tumor database2021 | Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial2019 | Publication without faculty affiliation
- Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial2019 | First Faculty of Medicine
